• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • Experts on Demand
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral Foods), 4th Edition, The

$150.00 – $300.00

Clear
SKU: KLI6126530 Category: Pharmaceuticals Market Research Pages: 220
  • Description
  • Table of Contents
  • Latest reports

Description

This Kalorama Information report – The World Market for Clinical Nutrition Products – focuses on three primary segments of essential medical nutrition:

  • Infant Nutrition: (Milk-based, Soy-based, Special Needs such as Chronic Reflux or Gastrointestinal Discomfort)
  • Enteral Nutrition (Standard and Fiber-containing Elemental and Semi-elemental, Specialized for Chronically Ill Patients)
  • Parenteral Nutrition

For each category, the report provides revenue data and forecasts for the most important segmentations.
The report includes incidence of conditions which often require enteral or parenteral feeding, birth rates, over 65 population, and overall global population. Information is presented as a worldwide overview, with special emphasis on the U.S., Europe, and other key markets. The market segments provide an overview, description of products on the market, new developments, market estimates and forecasts, and competitive analysis of leading providers. The report also includes current issues and trends affecting the industry.

Coverage of Issues and Trends in Clinical Nutrition

There are several issues and trends that are impacting the clinical nutrition market, including:

  • Wound Care Applications
  • Reimbursement of Nutrition Products
  • Food Programs Adjusted Numbers for Recession
  • Disease Statistics
  • Nursing Home and Hospice Trends
  • Nutrition and Education
  • DHA and ANA Additives
  • Counterfeit Infant Formulas
  • Infant Formula Recalls
  • Acquisition, Mergers and Alliances
  • Enteral Feeding Pumps

A Growing Market with Thriving Competition

Competition in the clinical nutrition market is dominated by a handful of companies, ranging from global nutritional manufacturers to leading pharmaceutical companies. The majority of competitive participation is in developed regions such as the United States, Western Europe, and Japan. However, many companies are expanding into less developed regions, intensifying competition in less tapped markets. China, for example, is among the expanding competitive regions as companies continue to break into the growing demand for clinical nutrition in new world markets. Companies highlighted in this study include:

  • Abbott
  • Baxter
  • B Braun
  • Danone
  • Fresenius Kabi
  • Hospira
  • Mead Johnson
  • Nestle
  • Perrigo Company
  • Pfizer

Revenues for each segment were generated using dollar and unit sales for each product.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 80 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with nutrition company representatives included marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers’ level. The base year for data was 2010. Historical data was provided for the years 2005 through 2009, with forecast data provided for 2011 through 2015. Compound annual growth rates (CAGRs) are provided for the 2005-2010, 2010-2015 and 2005-2015 periods for each industry segment covered. Competitive analysis is provided for the year 2010. The forecasted market analysis for 2010-2015 was based on demographic trends, new developments, and global expansion.

All Kalorama reports advertise the single user price. Use is limited to one user. We also feature department and global pricing for reports that we be utilized by more than one user at your company. Please consult ask your sales representative or select the correct license on our website.

For Kalorama’s take on the healthcare news of the week, based on our analysis of healthcare markets, follow Kalorama Information’s Key Point Blog at http://kaloramakeypoint.blogspot.com/

Table of Contents

EXECUTIVE SUMMARY

Introduction

Infant Nutrition

Enteral Nutrition

Parenteral Nutrition

Scope and Methodology

Size and Growth of the Market

Issues and Trends Affecting the Market

Leading Competitors

 

INTRODUCTION TO THE CLINICAL NUTRITION INDUSTRY

Introduction and History of Nutrition in the Clinical Setting

Defining Clinical Nutrition

Infant Nutrition

Enteral Nutrition

Parenteral Nutrition

Regulatory Environment

Environments for Clinical Nutrition

Hospital Settings

United States

International

Skilled Nursing Settings

United States

International

Home Care Settings

Hospice

Essential Nutrients

Carbohydrates

Proteins

Fats

Vitamins

Minerals

Demographics and Statistics

Worldwide Demographics

Global Aging Population

U.S. Aging Population

Cancer and Nutrition

Cardiovascular Disease and Nutrition

Diabetes and Nutrition

HIV/AIDS and Nutrition

Summary of Diseases

 

INFANT NUTRITION

Overview

Product Categories

Milk-based Formulas

Soy-based Formulas

Elemental Formulas

Probiotic/Prebiotic Infant Formula

Organic Infant Formula

Premature Infant Formulas

Lactose-free Formulas

Follow-Up Formulas

Other Specialized Formulas

Market Size and Growth

Global Market Introduction

Sales by Product Type

Global Markets

Competitive Analysis

 

ENTERAL NUTRITION

Overview

Product Categories

Industry Developments

Recent Ingredient Developments

Current Research Activities

New Product Launches

Market Size and Growth

Global Market Introduction

Sales by Product Type

Global Markets

Competitive Analysis

 

PARENTERAL NUTRITION

Overview

Product Categories

Amino Acids

Dextrose

Fats

Nutritional Additives

Industry Developments

Market Size and Growth

Global Market Introduction

Sales by Product Type

Global Markets

Competitive Analysis

 

TOTAL MARKET SIZE AND FORECAST

Total Market Size and Forecast

Global Market Overview

Sales by Broad Market Segment

Markets by Geographic Region

Competitor Analysis

 

ISSUES AND TRENDS AFFECTING THE NUTRITION MARKET

Introduction

Wound Care applications

Reimbursement of Nutrition Products

Food Programs

WIC

WHO

Nutrition and Education

The Registered Dietician

Dietician Statistics in the United States

DHA and ARA Additives

Counterfeit Infant Formulas

Recalls for Infant Formulas

Acquisitions, Mergers and Alliances

Enteral Feeding Pumps

Abbott Laboratories

Caesarea Medical Electronics

Covidien

Fresenius Kabi

Nestle Nutrition

Moog, Inc.

 

CORPORATE PROFILES

Introduction

Abbott

Baxter

B Braun

Danone

Fresenius Kabi

Hospira

Mead Johnson Nutrition

Nestlé

Perrigo

Pfizer/Wyeth

 

COMPANY DIRECTORY

 

LIST OF EXHIBITS

 

EXECUTIVE SUMMARY

Table 1-1

The Global Market for Clinical Nutrition 2005-2015

Figure 1-1

The Global Market for Clinical Nutrition 2005-2015

 

INTRODUCTION TO THE CLINICAL NUTRITION INDUSTRY

Table 2-1

Nutrient Requirements for Infant Formulas as Required by the FDA Infant Formula Act

Table 2-2

U.S. Registered Hospitals by Type, 2009

Figure 2-1

Number of Hospitals in the US, 1975-2009

Table 2-

Statistics for U.S. Hospitals, 2009

Table 2-3

U.S. Hospital Length of Stays, 2006-2008 Average by Broad Age Group

Registered Hospitals and Acute Care Centers by Country

Figure 2-2

Number of Nursing Homes in the U.S., 2001-2007

Table 2-5

Estimated Nursing Service Establishments and Care Centers by Country

Number of Home Care Agencies in the U.S., 1980-2007

Figure 2-4

Growth in Hospice Programs in the United States, 1998-2009

Figure 2-5

Patients Served with Hospice Programs in the United States, 1998-2009

Table 2-6

Percentage of Hospice Admissions by Primary Diagnosis, 2005 -2009 (% of Hospice Admissions)

Table 2-7

Essential Nutrients for Human Health

Table 2-8

World Population by Selected Geographical Region, 2010 – 2050

Figure 2-6

World Population by Selected Geographical Region, 2010-2050

Table 2-9

International Population Trend Age 65+

Figure 2-7

International Population Trend Age 65+

Table 2-10

Percent Population Over 65 by Year and Region, 2010-2050

Figure 2-8

Estimated World Population by Age, 2010 and 2050

Table 2-11

United States Population Trend Age 65+

Figure 2-9

United States Population Trend Age 65+

Table 2-12

World Cancer Incidence by Selected Types of Cancer, 2010 and 2020, all races, both sexes

Figure 2-10

Estimated and Projected World Cancer Incidence by Selected Types of Cancer, 2010 and 2020

Table 2-13

Total Cancer Incidence by Sex and Country, 2010 Estimates

Figure 2-11

Total Cancer Incidence by Sex and Country, 2010 Estimates

Table 2-14

Summary of Strength of Evidence on Lifestyle Factors and Risk of Developing Cancer

Table 2-15

Summary of Strength of Evidence on Lifestyle Factors and Risk of Developing Cardiovascular Diseases

Table 2-16

Summary of Strength of Evidence on Lifestyle Factors and Risk of Developing Type 2 Diabetes

Table 2-17

Total Number of People Living with HIV/AIDS, Newly Infected Population and Deaths, 2006 and 2008 by Region

Figure 2-12

The Role of Nutrition Education as HIV Infection Develops

Table 2-18

Hospital Utilization Measures for HIV Patients in the United States, 1990-2007

Table 2-19

Estimated Obesity by Country 2009 Estimates

Figure 2-13

Estimated Obesity by Country as a Portion of Total Population 2009 Estimates

Figure 2-14

Increases in Obesity by Country—2007 and 2009 Figures

Table 2-20

Summary of Strength of Evidence on Factors that Might Promote or Protect Against Weight Gain and Obesity

Table 2-21

Classification of Overweight in Adults According to BMI

Table 2-22

Prevalence/Incidence of Diseases by Type, 2010 Estimates

Table 2-15

Prevalence/Incidence of Disease by Type, 2010 Estimates

Table 2-16

Prevalence/Incidence of Disease by Type, 2010 Estimates

Table 2-23

Disease Mortality by Type, 2010 Estimates

Table 2-17

Disease Mortality by Type, 2010 Estimates

Table 2-18

Disease Mortality by Type, 2010 Estimates

 

INFANT NUTRITION

Table 3-1

Composition of Breast Milk (early and mature range) and Select Infant Formulas

Table 3-2

Live Births and Birth Rates by Country*

Table 3-1

Live Births by Country*

Table 3-2

Births Rates by Country*

Table 3-3

Children Under 5 Years*

Table 3-3

Marketed Infant Formulas (Manufacturer, Product Types, and Product Lines)

Table 3-4

The Market for Infant Nutrition 2005-2015

Figure 3-4

The Global Market for Infant Nutrition 2005-2015

Table 3-5

The Global Market for Infant Nutrition by Product Type (Milk-based, Soy-based, Specialized), 2010

Figure 3-5

The Global Market for Infant Nutrition by Product Type (Milk-based, Soy-based, Specialized), 2010

Table 3-6

The Global Market for Infant Nutrition Estimated Products Sales by Select Geographic Region, 2010

Figure 3-6

The Global Market for Infant Nutrition Market Share by Select Geographic Region, 2010

Table 3-7

The Global Market for Infant Nutrition Estimated Revenues and Market Share of Leading Suppliers 2010

Figure 3-7

The Global Market for Infant Nutrition Estimated Market Share by Leading Suppliers 2010

Table 3-8

The Global Market for Infant Nutrition Estimated Market Shares by Region for Leading Suppliers 2010

Figure 3-8

The Global Market for Infant Nutrition Estimated U.S. Market Shares for Leading Suppliers 2010

Figure 3-9

The Global Market for Infant Nutrition Estimated Market Shares Outside the U.S. for Leading Suppliers 2010

 

ENTERAL NUTRITION

Table 4-1

Aging Population, Percent of Total Population, and Annual Growth by Country*, 2010

Table 4-1

Over 65 Population by Country

Table 4-2

Over 65 Population as a Percent of Total Population by Country, 2010

Table 4-3

Over 65 Annual Population Growth by Country

Table 4-2

Marketed Pediatric and Adult Enteral Formulas (Manufacturer, Product Types, and Product Lines)

Table 4-3

The Market for Enteral Nutrition 2005-2015

Figure 4-4

The Global Market for Enteral Nutrition 2005-2015

Table 4-4

The Global Market for Enteral Nutrition by Product Type (Standard and Fiber-containing, Elemental and Semi-elemental, Specialized), 2010

Figure 4-5

The Global Market for Enteral Nutrition by Product Type (Standard and Fiber-containing, Elemental and Semi-elemental, Specialized), 2010

Table 4-5

The Global Market for Enteral Nutrition Estimated Products Sales by Select Geographic Region, 2010

Figure 4-6

The Global Market for Enteral Nutrition Market Share by Geographic Region, 2010

Table 4-6

The Global Market for Enteral Nutrition Estimated Revenues and Market Share of Leading Suppliers 2010

Figure 4-7

The Global Market for Enteral Nutrition Estimated Market Share by Leading Suppliers 2010

Table 4-7

The Global Market for Enteral Nutrition Estimated Market Shares by Region for Leading Suppliers 2010

Figure 4-8

The Global Market for Enteral Nutrition Estimated U.S. Market Shares for Leading Suppliers 2010

Figure 4-9

The Global Market for Enteral Nutrition Estimated Market Shares Outside the U.S. for Leading Suppliers 2010

 

PARENTERAL NUTRITION

Table 5-1

Aging Population, Percent of Total Population, and Annual Growth by Country*, 2010

Table 5-1

Over 65 Population by Country

Table 5-2

Over 65 Population as a Percent of Total Population by Country, 2010

Table 5-3

Over 65 Annual Population Growth by Country

Table 5-2

Standard Electrolyte Requirements

Table 5-3

Standard Parenteral Multivitamin Package* Vitamin

Table 5-4

Standard Parenteral Trace Elements Package

Table 5-5

Single Parenteral Trace Element Formulations

Table 5-6

Major Marketed Parenteral Formulas (Manufacturer, Product Types, and Product Lines)

Table 5-7

The Market for Parenteral Nutrition 2005-2015

Figure 5-4

The Global Market for Parenteral Nutrition 2005-2015

Table 5-8

The Global Market for Parenteral Nutrition by Product Type (Amino Acids, Dextrose, Fats Additives, Total) 2010

Figure 5-5

The Global Market for Parenteral Nutrition by Product Type (Amino Acids, Dextrose, Fats Additives, Total) 2010

Table 5-9

The Global Market for Parenteral Nutrition Estimated Products Sales by Select Geographic Region, 2010

Figure 5-6

The Global Market for Parenteral Nutrition Market Share by Select Geographic Region, 2010

Table 5-10

The Global Market for Parenteral Nutrition Estimated Revenues and Market Share of Leading Suppliers 2010

Figure 5-7

The Global Market for Parenteral Nutrition Estimated Market Share by Leading Suppliers 2010

Table 5-11

The Global Market for Parenteral Nutrition Estimated Market Shares by Region for Leading Suppliers 2010

Figure 5-8

The Global Market for Parenteral Nutrition Estimated U.S. Market Shares for Leading Suppliers 2010

Figure 5-9

The Global Market for Parenteral Nutrition Estimated Market Shares Outside the U.S. for Leading Suppliers 2010

 

TOTAL MARKET SIZE AND FORECAST

Table 6-1

The Global Market for Clinical Nutrition 2005-2015

Figure 6-1

The Global Market for Clinical Nutrition 2005-2015

Table 6-2

The Global Market for Clinical Nutrition by Product Type 2005-2015

Figure 6-2

The Global Market for Clinical Nutrition by Type 2005-2015

Figure 6-3

The Global Market for Clinical Nutrition by Type 2010

Figure 6-4

The Global Market for Clinical Nutrition by Type 2015

Table 6-3

The Global Market for Clinical Nutrition by Country 2008 and 2010

Figure 6-5

The Global Market for Clinical Nutrition by Country 2008 and 2010

Table 6-4

Leading Suppliers Clinical Nutrition Revenues and Significant Segments of Participation, 2010

Figure 6-6

Leading Suppliers Clinical Nutrition Estimated Market Shares, 2010

 

ISSUES AND TRENDS AFFECTING THE NUTRITION MARKET

Table 7-1

Abbott and Nestle Nutrition, Nutrition Products with Specific Wound Management Benefits

Table 7-2

Medicare Reimbursement for Home Parenteral and Enteral Nutrition; DME MAC

Table 7-3

Enteral Product Classification

Table 7-4

Example of DMEPOS Fee Schedule for Common Enteral Items

Table 7-5

Example of DMEPOS Fee Schedule for Common Parenteral Items

Table 7-6

WIC Participants by Participant Category in 2006 and 2009

Figure 7-1

Distribution of WIC Participants by Type, 2006

Figure 7-2

Distribution of WIC Participants by Type, 2009

Table 7-7

WIC Agencies and Distribution of Participants by State, 2008

Table 7-8

Dieticians and Nutritionists by Facility Type, 2009

Table 7-9

Highest Concentration of Dieticians and Nutritionists by State, 2009

Table 7-10

Recalls of Infant Feeding Products, 2001-2010

Table 7-11

Selected Enteral Feeding Pumps

 

CORPORATE PROFILES

 

COMPANY DIRECTORY

 

    Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals
    May 22, 2023
    Precision Cancer Therapeutics Market, 2022
    October 25, 2022
    The World Market for Vaccines, 2022-2027
    September 23, 2022
    Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022
    August 2, 2022

Related products

  • Placeholder image

    Type II Diabetes: The 45 Market in the United States for Drugs and Diagnostics

    $2,995.00 – $5,990.00
  • Placeholder image

    World Market for Anti-infectives Series: Volumes I – III – Antifungals, Antibacterials and Antivirals, The

    $6,000.00 – $12,000.00
  • Placeholder image

    Women’s Health: Worldwide Prescription Drug Markets – 3rd Edition

    $2,812.00 – $5,625.00
  • Placeholder image

    Early Stage Drug Discovery 2004: Combi-chem & High Throughput Screening Revisited

    $2,995.00 – $5,990.00

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Global Medtech Sales Exceed $500 Billion as Chronic Diseases Shape Market’s Future November 14, 2023
  • Healthcare Advances, Investments Support Laboratory Information System (LIS) Growth October 26, 2023
  • Personalized Medicine Key to IVD Procedure Volumes’ 10% Annual Growth October 19, 2023
  • RNA Sequencing: Life Sciences’ Transformative $2.6 Billion Industry October 4, 2023
  • How Globalization and Climate Change Impact COVID-19 and the IVD Market September 20, 2023

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Asian Vaccine Markets: India, China, Japan, Korea, Indonesia and Rest of As...Surgical Procedure Volumes in Europe
Scroll to top